Enterprise-wide license to Strainprint Analytics, Clinic Edition, will provide unparalleled medical cannabis treatment guidance.
For those aged 50 and older, men edged out women with respect to reporting efficacy of top-treated symptoms.
With pot legalized, job openings surge in Canada’s cannabis industry.
Have a listen to our Co-Founder & Chief Creative Officer, Stephanie Karasick as she interviews alongside Dr. Danial Schecter on the Alternative Food Network podcast on the Health Effects of Cannabis.
CEO’s Journey with Cannabis Helps Community “Use Cannabis Better”
Strainprint Technologies Ltd. Continues Rapid Growth, Welcoming Two New Senior Staff Members to the Expanding Team TORONTO, August 01, 2018 – Strainprint Technologies Ltd. (Strainprint™) – the leader in cannabis strain data and analytics – is excited to announce the addition of two key senior team members: Michelle Arbus, Vice President of Research & Insights, […]
On June 7-9th Strainprint participated in O’Cannabiz as a platinum sponsor. The weekend was filled with insightful panels, productive industry discussions, and invaluable networking! Have a look at our round-up from the action-packed weekend below! We look foward to next year!
On July 10th, 2018 Strainprint had the opportunity to participate in CannabisFest where our Founder, Stephanie Karasick participated in an AMA focused on how Entrepreneurs can prepare for legalization. https://betakit.com/cannabisfest-explores-how-entrepreneurs-can-prepare-for-legalization/
Dr. Caroline MacCallum, Dr. Danial Schecter & Dr. Dean Elterman Join Strainprint’s World-Class Medical Advisory Board TORONTO, April 17, 2018 /CNW/ – Strainprint, the leader in cannabis data & analytics, is pleased to announce that Dr. Caroline MacCallum, Dr. Danial Schecter and Dr. Dean Elterman have joined its Board of Medical Advisors. Strainprint works closely […]